Dear Past Trial Participant:
We need your
advice!
HIV prevention researchers
are trying to find better ways to collect information for future clinical
trials. We want to do a better job gathering feedback around risk behaviors for HIV infection and about how consistently people are really using
the products that are tested in clinical trials.
The questions below are designed to trigger your memories of clinical trial interviews but please feel free to share other ideas and thoughts you might have. You do not have to answer all of the questions in order.
We would
appreciate your thoughts in the following areas:
1) GENERAL
INFORMATION: How can we explain why the accuracy of reporting of risk
behaviors and actual use of trial products is so important?
During the
informed consent process, and during the trial itself, you may or may not have
been told how important information about HIV risk behaviors and use of the
study product is to making sure we correctly understand the results of the
study.
· In
your opinion, might a more specific explanation of the critical importance of this information be useful as a standard practice?
· Would
it help to explain how the science of the study really depends on this
information? Would it help to have an explanation of the consequences of inaccurate
information?
2) Environment - Internal & External: In your opinion, what type of environment works best to ensure real / accurate information is gathered?
·
What
about the outside environment might be significant – for example, does it
matter if the setting is a center dedicated to research or a research center combined
with a treatment center?
·
What
characteristics of the place in which this information is gathered matter – for
example, the room location within the clinic, sound proofing, movement of
people around the room, or anything else you think is important?
·
What
is the single most important thing about the clinic environment that may or may
not provide a sense of safety or confidence in talking about private and
sensitive information?
3) STAFF:
Who is best suited to gather this information?
·
Does
it matter what the gender, age, race/tribe, familiarity, professional level,
and language/vernacular of the interviewer is? Which aspects do you think are
important? Which are not so important?
·
What
is the single most important characteristic of the staff which is likely to
allow study participants to be as truthful as possible about sexual
risk/activity, about being able to follow the study regimen and use the
product, or other related private concerns?
·
Would
it be best to have two different staff do the following: one staff person to
ask about potential exposures to HIV, and another staff person who would
provide risk-reduction counseling? Would separating these staff functions
potentially allow for more openness and truthful responses? Or might the same
person be trusted to do both without influencing how people report their risk
behavior and consistence of following the study procedures and using the study
product?
4) METHODS/TOOLS: There are different ways in which information about sensitive behaviors is collected during a trial. These include: self-administered surveys (the participant fills it out directly); face-to-face interviews (an interviewer asks questions and the participant responds); computer assisted (ACASI) (the participants listens to questions over headphones and enters answers into a computer); or sometimes a combination of methods are used.
·
What
is your opinion on which method (or combination of methods) is best suited to have
volunteers report the most real and accurate sensitive information on risk
behaviors for HIV and actual use of the study product (adherence)?
·
The
accuracy of some information about human behavior depends on memory. Might it
be helpful to provide a question in which participants could report how confident
they feel in their ability to remember these pieces of information?
5) Barriers: Based on your experiences and understanding
of your community, what are the things we should avoid doing? For example,
·
In
your opinion, what are the biggest obstacles to volunteers in reporting
sensitive information related to risk behaviors and possible HIV exposure? What
might make volunteers comfortable sharing their true experiences?
·
If
you ever reported information that wasn’t accurate because of your discomfort
with the way questions were asked about
your risk behaviors to HIV or about your consistent use of (adherence to) the
study intervention?
6) ANYTHING
ELSE?
·
Is
there anything else you would like to share that might help us improve the quality
of the sensitive information we collect from volunteers on HIV risk behaviors
or adherence to product use in clinical trials?
Please share your
experiences and suggestions below. If you feel comfortable, please let us know
if you have even been a trial participant. Providing your name and contact information
are completely optional. You can also click here to share your thoughts in an email to HANC.
